BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25929998)

  • 1. Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia.
    Inaguma Y; Akatsuka Y; Hosokawa K; Maruyama H; Okamoto A; Katagiri T; Shiraishi K; Murayama Y; Tsuzuki-Iba S; Mizutani Y; Nishii C; Yamamoto N; Demachi-Okamura A; Kuzushima K; Ogawa S; Emi N; Nakao S
    Br J Haematol; 2016 Jan; 172(1):131-4. PubMed ID: 25929998
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia.
    Zaimoku Y; Takamatsu H; Hosomichi K; Ozawa T; Nakagawa N; Imi T; Maruyama H; Katagiri T; Kishi H; Tajima A; Muraguchi A; Kashiwase K; Nakao S
    Blood; 2017 May; 129(21):2908-2916. PubMed ID: 28232583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia.
    Nakao S; Takami A; Takamatsu H; Zeng W; Sugimori N; Yamazaki H; Miura Y; Ueda M; Shiobara S; Yoshioka T; Kaneshige T; Yasukawa M; Matsuda T
    Blood; 1997 May; 89(10):3691-9. PubMed ID: 9160674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsense mutation in HLA-B*40:02 in a case with acquired aplastic anaemia: a possible origin of clonal escape from autoimmune insult.
    Osumi T; Miharu M; Saji H; Kusunoki Y; Kojima H; Nakamura J; Shimada H
    Br J Haematol; 2013 Sep; 162(5):706-7. PubMed ID: 23701165
    [No Abstract]   [Full Text] [Related]  

  • 5. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
    Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
    Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
    Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
    Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack.
    Espinoza JL; Elbadry MI; Chonabayashi K; Yoshida Y; Katagiri T; Harada K; Nakagawa N; Zaimoku Y; Imi T; Takamatsu H; Ozawa T; Maruyama H; Hassanein HA; Khalifa A Noreldin A; Takenaka K; Akashi K; Hamana H; Kishi H; Akatsuka Y; Nakao S
    Blood Adv; 2018 Feb; 2(4):390-400. PubMed ID: 29472446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of a liver-infiltrating cytotoxic T-lymphocyte clone in concert with the development of hepatitis-associated aplastic anaemia.
    Ikawa Y; Nishimura R; Kuroda R; Mase S; Araki R; Maeba H; Wada T; Toma T; Koizumi S; Yachie A
    Br J Haematol; 2013 May; 161(4):599-602. PubMed ID: 23419100
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of clonal hematopoiesis in patients with acquired aplastic anemia].
    Nakao S
    Rinsho Ketsueki; 2013 Apr; 54(4):336-42. PubMed ID: 23666214
    [No Abstract]   [Full Text] [Related]  

  • 10. Viruses and bone marrow failure.
    Young NS; Rosenfeld S; Antunez-de-Mayolo J; Hibbs J; Liu J; Maciejewski J; St Jeor S; Shimomura S; Kajigaya S
    Schweiz Med Wochenschr Suppl; 1991; 43():28-32. PubMed ID: 1843035
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro test for detecting auto-suppressive T lymphocytes in bone marrow from patients with aplastic anemia.
    Hanada T; Abe T
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):904-9. PubMed ID: 2932879
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppressive lymphocytes against CFU-C in relation to therapeutic response to glucocorticoid in patients with aplastic anemia.
    Takahashi T; Sugiyama H; Yagita M; Imura H; Iho S; Hoshino T; Okada T; Okada H
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):910-20. PubMed ID: 2932880
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in peripheral blood of children with aplastic anaemia].
    Huang YL; Huang SL; Fang JP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):794-5. PubMed ID: 17229390
    [No Abstract]   [Full Text] [Related]  

  • 14. Acquired aplastic anemia: antibody-mediated hematopoietic failure.
    Freedman MH; Gelfand EW; Saunders EF
    Am J Hematol; 1979; 6(2):135-41. PubMed ID: 314237
    [No Abstract]   [Full Text] [Related]  

  • 15. Aplastic anaemia and polyneuropathy.
    Foster PN; Kelsey PR
    Acta Haematol; 1983; 70(3):202-4. PubMed ID: 6410647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune pathophysiology of refractory anemias].
    Nakao S
    Nihon Rinsho; 2008 Mar; 66(3):453-9. PubMed ID: 18326316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune pathophysiology of acquired aplastic anaemia.
    Young NS
    Eur J Haematol Suppl; 1996; 60():55-9. PubMed ID: 8987242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.
    Vonderheide RH; Anderson KS; Hahn WC; Butler MO; Schultze JL; Nadler LM
    Clin Cancer Res; 2001 Nov; 7(11):3343-8. PubMed ID: 11705846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of in vitro cultures to the elucidation of the pathogenesis of aplastic anaemia.
    Haak HL; Goselink HM; Sabbe L; Veenhof WF; Bogers AJ; Waayer JL
    Haematol Blood Transfus; 1979; 24():259-64. PubMed ID: 396180
    [No Abstract]   [Full Text] [Related]  

  • 20. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.